Showing results (511-520 of 531) with videos related to
Sort By:
Pageof 54
Cell Systems|October 23, 2020
Large-Scale Multi-omic Analysis of COVID-19 SeverityKatherine A Overmyer, Evgenia Shishkova, Ian J Miller, et al.American Journal of Medical Genetics. Part A|June 6, 2020
Activating variants in PDGFRB result in a spectrum of disorders responsive to imatinib monotherapyTara L Wenger, Randall A Bly, Natalie Wu, et al.JAMA|February 8, 2018
Prevalence of Fetal Alcohol Spectrum Disorders in 4 US CommunitiesPhilip A May, Christina D Chambers, Wendy O Kalberg, et al.Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Large-scale Multi-omic Analysis of COVID-19 SeverityKatherine A Overmyer, Evgenia Shishkova, Ian J Miller, et al.Biorxiv : the Preprint Server for Biology|July 29, 2024
Effects of clinically relevant radionuclides on the activation of a type I interferon response by radiopharmaceuticals in syngeneic murine tumor modelsCaroline P Kerr, Julia Sheehan-Klenk, Joseph J Grudzinski, et al.Cancer Immunology Research|May 29, 2025
The Effects of Clinically Relevant Radionuclides on the Activation of an IFN1 Response Correlate with Radionuclide Half-life and Linear Energy Transfer and Influence Radiopharmaceutical Antitumor EfficacyCaroline P Kerr, Julia Sheehan-Klenk, Joseph J Grudzinski, et al.Prenatal Diagnosis|November 14, 2024
Fetal Presentation of MYRF-Related Cardiac Urogenital Syndrome: An Emerging and Challenging Prenatal DiagnosisMaud Favier, Elise Brischoux-Boucher, Louise C Pyle, et al.Genetics in Medicine Open|November 1, 2024
Clinical RNA sequencing clarifies variants of uncertain significance identified by prior testingJonathan Marquez, Jennifer N Cech, Cate R Paschal, et al.Journal of Medicinal Chemistry|November 3, 2015
Triphenylethanamine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors: Discovery of N-[(1R)-1-(3-Cyclopropoxy-4-fluorophenyl)-1-[3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl]-2-phenylethyl]-4-fluoro-3-(trifluoromethyl)benzamide (BMS-795311)Jennifer X Qiao, Tammy C Wang, Leonard P Adam, et al.American Journal of Human Genetics|May 15, 2010
Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomaliesDavid T Miller, Margaret P Adam, Swaroop Aradhya, et al.Pageof 54